
Current Price | $1.32 | Mkt Cap | $198.1M |
---|---|---|---|
Open | $1.23 | P/E Ratio | -1.37 |
Prev. Close | $1.32 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.16 - $1.34 | Volume | 290 |
52-Wk Range | $0.50 - $3.41 | Avg. Daily Vol. | 2,892,370 |
A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
Current Price | $1.32 | Mkt Cap | $198.1M |
---|---|---|---|
Open | $1.23 | P/E Ratio | -1.37 |
Prev. Close | $1.32 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.16 - $1.34 | Volume | 290 |
52-Wk Range | $0.50 - $3.41 | Avg. Daily Vol. | 2,892,370 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bull criteria. Explain
If this upsets you, start recommending pitches below!
I shorted 1000 shares of Heron with a cost basis of 17.22 in the after hours after the company reported positive topline data from the MAGIC phase III of Sustol for highly emetogenic chemotherapy. I didn't think the initial gains were sustainable… More
Read the most recent pitches from players about HRTX.
Recs
Once the fda arrives their brew product, the stock will do very well.
Recs
03/27/2013 PDUFA of APF530 for prevention of acute and delayed onset chemotherapy induced nausea and vomiting.
Find the members with the highest scoring picks in HRTX.
IdahoInvestor (99.66) Score: +336.14
The Score Leader is the player with the highest score across all their picks in HRTX.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
IdahoInvestor | 99.66 | 11/14/2012 |
![]() |
5Y | $10.80 | -87.78% | +234.33% | +322.11 | 0 Comment | |
sinvestor | 72.18 | 1/14/2014 |
![]() |
3M | $10.00 | -86.80% | +151.87% | +238.67 | 0 Comment | |
MMCapitalMgmt | 95.90 | 9/1/2015 |
![]() |
5Y | $37.30 | -96.46% | +137.73% | +234.19 | 0 Comment | |
OregonState | < 20 | 9/2/2015 |
![]() |
5Y | $37.01 | -96.43% | +135.90% | +232.33 | 0 Comment | |
rjanina41 | < 20 | 2/22/2016 |
![]() |
3M | $18.19 | -92.74% | +136.81% | +229.55 | 0 Comment | |
ziggystraw | 90.93 | 11/23/2015 |
![]() |
5Y | $25.77 | -94.88% | +119.27% | +214.14 | 0 Comment | |
km00nster | < 20 | 6/1/2015 |
![]() |
5Y | $21.14 | -93.76% | +116.62% | +210.37 | 0 Comment | |
johnnyrocku | 99.75 | 6/1/2015 |
![]() |
5Y | $19.60 | -93.27% | +116.96% | +210.22 | 0 Comment | |
Momentum21 | 34.30 | 4/5/2018 |
![]() |
5Y | $28.55 | -95.38% | +72.38% | +167.76 | 0 Comment | |
WildShaman | 78.47 | 7/9/2018 |
![]() |
5Y | $40.85 | -96.77% | +66.01% | +162.78 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.